Literature DB >> 23638738

Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?

Ayato Takada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23638738     DOI： 10.2217/imt.13.29

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  4 in total

1.  Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.

Authors:  Alexander Gutfraind; Lauren Ancel Meyers
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

2.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

3.  Ebola virus disease.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-05       Impact factor: 2.471

4.  Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.

Authors:  Olivier Reynard; Frédéric Jacquot; Gwénaëlle Evanno; Hoa Le Mai; Apolline Salama; Bernard Martinet; Odile Duvaux; Jean-Marie Bach; Sophie Conchon; Jean-Paul Judor; Andrea Perota; Irina Lagutina; Roberto Duchi; Giovanna Lazzari; Ludmilla Le Berre; Hélène Perreault; Elsa Lheriteau; Hervé Raoul; Viktor Volchkov; Cesare Galli; Jean-Paul Soulillou
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.